Find a South Orange Eye Doctor at Practice Northern New Jersey Eye Institute on ZocDoc
Phone: 973-763-2203 Fax: 973-762-9449
Text Size: Normal Large
Glaucoma Clinical Studies Led by Dr. Crane
Dr. Crane is currently a Principal Investigator for three FDA studies. Two are for patients with Glaucoma and the other is for patients with Meibomian Gland Dysfunction.
For information on any of these studies please call our office and ask for Mary K or Shirley. You can also find more information at the Lunar Glaucoma Study website.
iDose
"Dr. Crane is one of less than 100 doctors in the United States to be able to bring this new technology to his patients."
"Dr. Crane is one of less than 100 doctors in the world who have been approved to participate in the iDose FDA trial"
iDose exchange
"Dr. Crane is one of less than 15 doctors in the United States to perform this procedure for his patients."
"Dr. Crane is one of less than 15 doctors in the world who were approved to participate in the iDose exchange FDA trial"
Infinite
"Dr. Crane is one of less than 15 doctors in the United States who were able to bring this new technology to his patients."
"Dr. Crane is one of less than 15 doctors who were approved to participate in the iStent Infinite FDA trial"
General
FDA issues warning for contaminated eye drops that can cause infection.
"Dr. Crane and Glaukos have a long history of working together on several medical device and pharmaceutical studies. He has been able to offer these technologies to his patients and the products from these studies have progressed to help treat hundreds of thousands of patients in need."
Employment Opportunity: Optometrist in Essex, Morris, and Union Counties
Dr. Crane Top Doctor 2019
Congratulations to Dr. Crane for being the 2nd surgeon in the United States to perform a new treatment for Glaucoma. We hope this treatment will bring further advances in the care of our glaucoma.
ASCRS Thanks Dr. Crane for Volunteer Work
Dr. Spier Named to OSN's Premier Surgeon 300
Dr. Spier: Weekend Comedian
Dionne Warwick on Dropless Surgery [VIDEO] (Surgery Performed by Dr. Spier)
Dr. Crane and Staff congratulate their patient Dr. William Scaife
Dr. Crane named to the ASCRS Council of 100
"Dr. Crane is one of less than 100 doctors in the United States to be able to bring this new technology to his patients."
"Dr. Crane is one of less than 100 doctors in the world who have been approved to participate in the iDose FDA trial"
iDose exchange
"Dr. Crane is one of less than 15 doctors in the United States to perform this procedure for his patients."
"Dr. Crane is one of less than 15 doctors in the world who were approved to participate in the iDose exchange FDA trial"
Infinite
"Dr. Crane is one of less than 15 doctors in the United States who were able to bring this new technology to his patients."
"Dr. Crane is one of less than 15 doctors who were approved to participate in the iStent Infinite FDA trial"
General
FDA issues warning for contaminated eye drops that can cause infection.
"Dr. Crane and Glaukos have a long history of working together on several medical device and pharmaceutical studies. He has been able to offer these technologies to his patients and the products from these studies have progressed to help treat hundreds of thousands of patients in need."
Employment Opportunity: Optometrist in Essex, Morris, and Union Counties
Dr. Crane Top Doctor 2019
Congratulations to Dr. Crane for being the 2nd surgeon in the United States to perform a new treatment for Glaucoma. We hope this treatment will bring further advances in the care of our glaucoma.
ASCRS Thanks Dr. Crane for Volunteer Work
Dr. Spier Named to OSN's Premier Surgeon 300
Dr. Spier: Weekend Comedian
Dionne Warwick on Dropless Surgery [VIDEO] (Surgery Performed by Dr. Spier)
Dr. Crane and Staff congratulate their patient Dr. William Scaife
Dr. Crane named to the ASCRS Council of 100
Dr Crane meets one of his favorite Sharks, Daymond John, at a book signing!
Dr Spier discusses the implant (Toric) for astigmatism correction
Florence Henderson Discusses Crystalens
